UnknownNot Applicable

Effects of the Combining Physical Exercise and Cognitive Training for the Community-based Elderly

Taiwan90 participantsStarted 2022-03-01

Plain-language summary

This study aims to (1) determine the intervention effects of sequential and simultaneous training on cognitive function and health-related function for cognitively-normal elderly and elderly with Mild Cognitive Impairment(MCI) and Subjective Cognitive Decline(SCD); (2) compare which combination approach is more advantageous for improvement on outcome measures.

Who can participate

Age range60 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. age≥60
✓. able to follow instruction
✓. MoCA\>26
✓. not SCD or MCI or Dementia

Exclusion criteria

✕. concomitant neurological conditions such as dementia, Parkinson's disease, brain tumor, brain injury and other brain diseases (such as intracranial hypertension or cerebral edema);
✕. have unstable cardiovascular status such as uncontrolled hypertension
✕. age\>=60
✕. SCD(from Ecog-12)
✕. MoCA≥26
✕. not MCI or Dementia
✕. concomitant neurological conditions such as dementia, Parkinson's disease, brain tumor, brain injury and other brain diseases (such as intracranial hypertension or cerebral edema);
✕. have unstable cardiovascular status such as uncontrolled hypertension

What they're measuring

Change scores of the Montreal Cognitive Assessment (MoCA).

Timeframe: baseline, after the intervention eight weeks, and at 3-month follow-up.

Change scores of Wechsler Memory Scale (WMS)

Timeframe: baseline, after the intervention eight weeks, and at 3-month follow-up.

Change scores of Stroop test

Timeframe: baseline, after the intervention eight weeks, and at 3-month follow-up.

Change scores of Color trials test

Timeframe: baseline, after the intervention eight weeks, and at 3-month follow-up.

Trial details

NCT IDNCT05225181

SponsorChang Gung Memorial Hospital

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2023-12-31

Contact for this trial

Ching-yi Wu, ScD

#886-3-2118800 cywu@mail.cgu.edu.tw

View on ClinicalTrials.gov More Cognitively-normal trials

Plain-language summary

Who can participate

Age range60 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. age≥60
✓. able to follow instruction
✓. MoCA\>26
✓. not SCD or MCI or Dementia

Exclusion criteria

✕. concomitant neurological conditions such as dementia, Parkinson's disease, brain tumor, brain injury and other brain diseases (such as intracranial hypertension or cerebral edema);
✕. have unstable cardiovascular status such as uncontrolled hypertension
✕. age\>=60
✕. SCD(from Ecog-12)
✕. MoCA≥26
✕. not MCI or Dementia
✕. concomitant neurological conditions such as dementia, Parkinson's disease, brain tumor, brain injury and other brain diseases (such as intracranial hypertension or cerebral edema);
✕. have unstable cardiovascular status such as uncontrolled hypertension

What they're measuring

Change scores of the Montreal Cognitive Assessment (MoCA).

Timeframe: baseline, after the intervention eight weeks, and at 3-month follow-up.

Change scores of Wechsler Memory Scale (WMS)

Timeframe: baseline, after the intervention eight weeks, and at 3-month follow-up.

Change scores of Stroop test

Timeframe: baseline, after the intervention eight weeks, and at 3-month follow-up.

Change scores of Color trials test

Timeframe: baseline, after the intervention eight weeks, and at 3-month follow-up.